Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1996
08/27/1996US5550118 Polyhydronorharman synthase inhibitors
08/27/1996US5550116 Anticoagulants
08/27/1996US5550113 Mixture of insulin and a metal complex
08/27/1996US5550112 Skin ulcer therapy
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550107 Anticarcinogenic agents and antiestrogens
08/27/1996US5550042 Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
08/27/1996US5550028 Tetrahydroxyquinone as an activator component for activated partial thromboplastin time test of blood coagulation
08/27/1996US5549915 Magnetically responsive composition for carrying biologically active substances and methods of production
08/27/1996US5549912 Controlled release oxycodone compositions
08/27/1996US5549911 Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
08/27/1996US5549906 Nicotine lozenge and therapeutic method for smoking cessation
08/27/1996US5549901 Antimicrobial oil-in-water emulsions
08/27/1996US5549893 Use of protein C in the treatment of purpura fulminans
08/27/1996US5549888 Acidic mixtures containing salicyclic, retinoic, azelaic, lactic, glycolic or pyruvic acids, water soluble glycol ethers and nonionic surfactants
08/27/1996US5549885 Fungicides, antiyeast agents for oral application
08/27/1996US5549674 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/27/1996CA2046345C Functional food
08/27/1996CA2004366C Anti-infection and antithrombogenic medical articles and method for their preparation
08/27/1996CA2001673C Pharmaceutical composition containing piroxicam
08/27/1996CA1338561C Aromatic esters and thioesters; process for preparing the same and their use in human or animal medecine and in cosmetics
08/27/1996CA1338556C 4-substituted imidazole derivatives useful in perioperative care
08/27/1996CA1338555C Agents for treatment of male impotence
08/27/1996CA1338554C Combination of tobramycin and steroids for topical ophthalmic use
08/25/1996CA2170227A1 Novel retinoids
08/25/1996CA2164059A1 Cosmetic compositions for treating itchy skin
08/22/1996WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996WO1996025499A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025440A1 Polymeric compounds
08/22/1996WO1996025437A1 Process for producing chitosan-glucan complexes, compounds producible therefrom and their use
08/22/1996WO1996025426A1 Novel dipeptide amidines as thrombin inhibitors
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025414A1 Imidazo[1,2-a]pyridines for the treatment of cns and cardiac diseases
08/22/1996WO1996025411A1 Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
08/22/1996WO1996025409A1 Cosmetic or pharmaceutical compositions containing an ozonide-enriched natural vegetable oil, and uses thereof
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025403A1 α-SUBSTITUTED HYDRAZIDES HAVING CALPAIN INHIBITORY ACTIVITY
08/22/1996WO1996025402A1 Novel uses for barbituric acid analogs
08/22/1996WO1996025397A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996WO1996025392A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
08/22/1996WO1996025387A1 Alkylcarboxy amino acids-modulators of the kainate receptor
08/22/1996WO1996025384A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/22/1996WO1996025383A1 Anti-inflammatory benzoic acid derivatives
08/22/1996WO1996025380A1 The use of tributyrin in the treatment of inflammatory bowel disease
08/22/1996WO1996025184A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression
08/22/1996WO1996025176A1 Therapeutic inhibitor of vascular smooth muscle cells
08/22/1996WO1996025169A2 Non-anticoagulant heparinoids for treating hypovolemic shock
08/22/1996WO1996025168A1 Use of hyaluronic acid for the treatment of interstitial cystitis
08/22/1996WO1996025167A1 Anti-viral triaza compounds
08/22/1996WO1996025166A1 Method of lessening the risk of vertebral fractures
08/22/1996WO1996025165A1 Method of lessening the risk of non-vertebral bone fractures
08/22/1996WO1996025164A1 Use of dehydroepiandrosterone to treat depression
08/22/1996WO1996025163A1 Treatment of herpes simplex viruses
08/22/1996WO1996025162A1 Means for treating onychomycosis
08/22/1996WO1996025161A1 Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
08/22/1996WO1996025160A1 The use of heterocyclic compounds
08/22/1996WO1996025159A1 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
08/22/1996WO1996025158A1 Medicinal composition containing azulene derivative and process for producing the same
08/22/1996WO1996025157A1 Il-8 receptor antagonists
08/22/1996WO1996025156A1 Use of matrix metalloproteinase inhibitors for the treatment of diseases mediated by tgf-alpha
08/22/1996WO1996025154A1 Transdermal formulation
08/22/1996WO1996025142A1 Use of galactosylglycerides and of naturally occurring extracts containing such products in cosmetics, pharmaceutics and particularly dermatology
08/22/1996WO1996025045A1 Thiols to promote hematopoietic progenitor cell growth
08/22/1996WO1996025042A1 Transdermal formulation
08/22/1996DE19549330A1 Use of fluoro-uracil to treat nail fungus
08/22/1996DE19507820A1 Neuartig substituierte DTPA-Derivate, deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik, sowie Verfahren zur Herstellung der Komplexe und Mittel Novel substituted DTPA derivatives, their metal complexes, pharmaceutical agents containing these complexes, their use in diagnostics, as well as methods to prepare the complexes and agents
08/22/1996DE19506885A1 Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneolderivate, processes for their preparation and their pharmaceutical use
08/22/1996DE19505960A1 Konjugat zur individuellen Dosierung von Arzneimitteln A conjugate for individual dosing of drugs
08/22/1996DE19505100A1 Alk(en)yldicarbonsäurebisester, deren Verwendung sowie Verfahren zu deren Herstellung Alk (en) yldicarbonsäurebisester, their use and processes for their preparation
08/22/1996DE19503995A1 Decreasing mortality from congestive heart failure using carbazole derivs.
08/22/1996CA2559392A1 Therapeutic inhibitor of vascular smooth muscle cells
08/22/1996CA2216648A1 Alkylcarboxy amino acids-modulators of the kainate receptor
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2213233A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996CA2213211A1 New borneol derivatives, process for their production, and their pharmaceutical use
08/22/1996CA2213094A1 Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
08/22/1996CA2213076A1 Method of lessening the risk of vertebral fractures
08/22/1996CA2212996A1 Method of lessening the risk of non-vertebral bone fractures
08/22/1996CA2212874A1 Transdermal formulation
08/22/1996CA2212631A1 Anti-inflammatory benzoic acid derivatives
08/22/1996CA2211920A1 Anti-viral triaza compounds
08/22/1996CA2211836A1 Indole derivatives with affinity for the cannabinoid receptor
08/22/1996CA2211674A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
08/22/1996CA2211162A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996CA2211109A1 Novel thrombin inhibitors
08/22/1996CA2210000A1 Polymeric compounds
08/22/1996CA2208073A1 Alpha-substituted hydrazides having calpain inhibitory activity
08/22/1996CA2143064A1 Treatment of mild depression and restoration of igf-1 levels in aging by dehydroepiandrosterone
08/21/1996EP0727438A2 Adducts of PEG and GM-CSF
08/21/1996EP0727437A2 Covalent PEG-protein adducts
08/21/1996EP0727433A1 Process for the preparation of 1-(2'-deoxy-2',2'-difluoro-d-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-beta-d-ribo-pentopyranose
08/21/1996EP0727430A1 Improvements in PT complexes
08/21/1996EP0727426A2 Cephalosporin derivatives
08/21/1996EP0727425A1 Adhesion receptor antagonists
08/21/1996EP0727421A1 Agents for improving sleep
1 ... 6887 6888 6889 6890 6891 6892 6893 6894 6895 6896 6897 6898 6899 6900 6901 6902 6903 6904 6905 6906 6907 ... 7860